DexCom is trading 4.49% down at $83.04 following a sharp pullback from the prior session’s close of $86.94, likely reacting to normal post-rally volatility.

  • No major company-specific news, earnings updates, or FDA events have been reported to explain the downward move.
  • The decline occurs despite broader strength in the healthcare sector, with the XLV sector trading up 1.31%.